38 related articles for article (PubMed ID: 10557087)
1. Insertional mutagenesis and deep profiling reveals gene hierarchies and a Myc/p53-dependent bottleneck in lymphomagenesis.
Huser CA; Gilroy KL; de Ridder J; Kilbey A; Borland G; Mackay N; Jenkins A; Bell M; Herzyk P; van der Weyden L; Adams DJ; Rust AG; Cameron E; Neil JC
PLoS Genet; 2014 Feb; 10(2):e1004167. PubMed ID: 24586197
[TBL] [Abstract][Full Text] [Related]
2. LncRNA CCAT1 promotes prostate cancer cells proliferation, migration, and invasion through regulation of miR-490-3p/FRAT1 axis.
Cai X; Dai Y; Gao P; Ren G; Cheng D; Wang B; Wang Y; Yu J; Du Y; Wang X; Xue B
Aging (Albany NY); 2021 Jul; 13(14):18527-18544. PubMed ID: 34319909
[TBL] [Abstract][Full Text] [Related]
3. STAT1 is a modulator of the expression of frequently rearranged in advanced T-cell lymphomas 1 expression in U251 cells.
Guo G; Wang S; Hao Y; Ren Y; Wu Y; Zhang J; Liu D
Oncol Lett; 2020 Jul; 20(1):248-256. PubMed ID: 32565951
[TBL] [Abstract][Full Text] [Related]
4. RNA sequencing reveals widespread transcriptome changes in a renal carcinoma cell line.
Lichawska-Cieslar A; Pietrzycka R; Ligeza J; Kulecka M; Paziewska A; Kalita A; Dolicka DD; Wilamowski M; Miekus K; Ostrowski J; Mikula M; Jura J
Oncotarget; 2018 Feb; 9(9):8597-8613. PubMed ID: 29492220
[TBL] [Abstract][Full Text] [Related]
5. Frequently rearranged in advanced T‑cell lymphomas‑1 demonstrates oncogenic properties in prostate cancer.
Zhang W; Xiong H; Zou Y; Xu S; Quan L; Yuan X; Xu N; Wang Y
Mol Med Rep; 2016 Oct; 14(4):3551-8. PubMed ID: 27599661
[TBL] [Abstract][Full Text] [Related]
6. Silencing of FRAT1 by siRNA inhibits the proliferation of SGC7901 human gastric adenocarcinoma cells.
Yu Q; Shang LU; Yu H; Yang Z; Xu D
Biomed Rep; 2016 Feb; 4(2):223-226. PubMed ID: 26893843
[TBL] [Abstract][Full Text] [Related]
7. The clinical significance of FRAT1 and ABCG2 expression in pancreatic ductal adenocarcinoma.
Yuan Y; Yang Z; Miao X; Li D; Liu Z; Zou Q
Tumour Biol; 2015 Dec; 36(12):9961-8. PubMed ID: 26178481
[TBL] [Abstract][Full Text] [Related]
8. Genetic Modeling of PIM Proteins in Cancer: Proviral Tagging and Cooperation with Oncogenes, Tumor Suppressor Genes, and Carcinogens.
Aguirre E; Renner O; Narlik-Grassow M; Blanco-Aparicio C
Front Oncol; 2014; 4():109. PubMed ID: 24860787
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of FRAT1 expression by RNA interference inhibits human glioblastoma cell growth, migration and invasion.
Guo G; Kuai D; Cai S; Xue N; Liu Y; Hao J; Fan Y; Jin J; Mao X; Liu B; Zhong C; Zhang X; Yue Y; Liu X; Ma N; Guo Y
PLoS One; 2013; 8(4):e61206. PubMed ID: 23613813
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of Frat1 correlates with malignant phenotype and advanced stage in human non-small cell lung cancer.
Zhang Y; Yu JH; Lin XY; Miao Y; Han Y; Fan CF; Dong XJ; Dai SD; Wang EH
Virchows Arch; 2011 Sep; 459(3):255-63. PubMed ID: 21818639
[TBL] [Abstract][Full Text] [Related]
11. FRAT1 expression and its correlation with pathologic grade, proliferation, and apoptosis in human astrocytomas.
Guo G; Liu B; Zhong C; Zhang X; Mao X; Wang P; Jiang X; Huo J; Jin J; Liu X; Chen X
Med Oncol; 2011 Mar; 28(1):1-6. PubMed ID: 20041315
[TBL] [Abstract][Full Text] [Related]
12. Concurrent FSGS and Hodgkin's lymphoma: case report and literature review on the link between nephrotic glomerulopathies and hematological malignancies.
Mallouk A; Pham PT; Pham PC
Clin Exp Nephrol; 2006 Dec; 10(4):284-9. PubMed ID: 17186334
[TBL] [Abstract][Full Text] [Related]
13. Tissue microarray analysis of human FRAT1 expression and its correlation with the subcellular localisation of beta-catenin in ovarian tumours.
Wang Y; Hewitt SM; Liu S; Zhou X; Zhu H; Zhou C; Zhang G; Quan L; Bai J; Xu N
Br J Cancer; 2006 Mar; 94(5):686-91. PubMed ID: 16479254
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of Frat1 in transgenic mice leads to glomerulosclerosis and nephrotic syndrome, and provides direct evidence for the involvement of Frat1 in lymphoma progression.
Jonkers J; Weening JJ; van der Valk M; Bobeldijk R; Berns A
Oncogene; 1999 Oct; 18(44):5982-90. PubMed ID: 10557087
[TBL] [Abstract][Full Text] [Related]
15. Activation of a novel proto-oncogene, Frat1, contributes to progression of mouse T-cell lymphomas.
Jonkers J; Korswagen HC; Acton D; Breuer M; Berns A
EMBO J; 1997 Feb; 16(3):441-50. PubMed ID: 9034327
[TBL] [Abstract][Full Text] [Related]
16. Pim1 cooperates with E2a-Pbx1 to facilitate the progression of thymic lymphomas in transgenic mice.
Feldman BJ; Reid TR; Cleary ML
Oncogene; 1997 Nov; 15(22):2735-42. PubMed ID: 9401000
[TBL] [Abstract][Full Text] [Related]
17. Moloney murine leukemia virus infection accelerates lymphomagenesis in E mu-bcl-2 transgenic mice.
Shinto Y; Morimoto M; Katsumata M; Uchida A; Aozasa K; Okamoto M; Kurosawa T; Ochi T; Greene MI; Tsujimoto Y
Oncogene; 1995 Nov; 11(9):1729-36. PubMed ID: 7478600
[TBL] [Abstract][Full Text] [Related]
18. Pim-1: a serine/threonine kinase with a role in cell survival, proliferation, differentiation and tumorigenesis.
Wang Z; Bhattacharya N; Weaver M; Petersen K; Meyer M; Gapter L; Magnuson NS
J Vet Sci; 2001 Dec; 2(3):167-79. PubMed ID: 12441685
[TBL] [Abstract][Full Text] [Related]
19. Tumorigenesis in transgenic mice: identification and characterization of synergizing oncogenes.
Berns A
J Cell Biochem; 1991 Oct; 47(2):130-5. PubMed ID: 1661736
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
